Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Use of the Impella ECP in Patients Undergoing an Elective or Urgent High-Risk Percutaneous Coronary Intervention: An Early Feasibility Study

NCT04477603 is registered in ClinicalTrials.gov with Abiomed Inc. as lead sponsor.

NCT NCT04477603
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04477603 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Use of the Impella ECP in Patients Undergoing an Elective or Urgent High-Risk Percutaneous Coronary Intervention: An Early Feasibility Study
Lead sponsor
Abiomed Inc.
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 9, 2020
Completion date
October 31, 2026
Enrollment
100 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

high-risk percutaneous coronary intervention